Peter Manley has extensive experience as a finance professional in the life sciences industry.
Mr Manley joined Genetic Signatures in October 2018 as chief financial officer and company secretary. He successfully led a capital raise of $37.5m for the group.
Mr Manley was the chief financial officer and company secretary of AtCor Medical Holdings (now Cardiex) and Sirtex Medical, and had held financial positions in a variety of large Australian and foreign-owned corporations including 8 years with Dow Chemical and 4 years at Goodman Fielder.